Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 3Active not recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 32Carcinoma, Non-Small-Cell Lung 29Leukemia, Myeloid, Acute 27Melanoma 25Neoplasms 22Lymphoma 21Pancreatic Neoplasms 18Multiple Myeloma 18Recurrence 17Lung Neoplasms 17Leukemia 17Ovarian Neoplasms 16Neoplasm Metastasis 15Lymphoma, Non-Hodgkin 15Carcinoma, Hepatocellular 15Colorectal Neoplasms 14Lymphoma, Follicular 13Myelodysplastic Syndromes 12Lymphoma, B-Cell 12Leukemia, Lymphocytic, Chronic, B-Cell 12Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Prostatic Neoplasms 10Lymphoma, Mantle-Cell 10Brain Neoplasms 10Stomach Neoplasms 9Squamous Cell Carcinoma of Head and Neck 9Liver Neoplasms 9Glioma 9

Interventions

pembrolizumab 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Withdrawn × Clear-cell metastatic renal cell carcinoma × Clear all
NCT06361810 2025-08-19

PSMA Therapy and Immunotherapy in Kidney Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Withdrawn
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡